TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 37 filers reported holding TRINITY BIOTECH PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $995,000 | -47.5% | 492,397 | -43.4% | 0.09% | -48.5% |
| Q2 2020 | $1,897,000 | +94.8% | 870,000 | -1.7% | 0.17% | +62.5% |
| Q1 2020 | $974,000 | +43.0% | 885,300 | +34.4% | 0.10% | +108.0% |
| Q4 2019 | $681,000 | -0.3% | 658,777 | +16.7% | 0.05% | -3.8% |
| Q3 2019 | $683,000 | -53.2% | 564,663 | -36.2% | 0.05% | -51.4% |
| Q2 2019 | $1,460,000 | -42.1% | 884,700 | 0.0% | 0.11% | -42.5% |
| Q1 2019 | $2,521,000 | +24.4% | 884,700 | 0.0% | 0.19% | +11.4% |
| Q4 2018 | $2,026,000 | -36.1% | 884,700 | +11.6% | 0.17% | -21.2% |
| Q3 2018 | $3,170,000 | -26.7% | 792,456 | -8.4% | 0.21% | -25.6% |
| Q2 2018 | $4,327,000 | -28.5% | 865,400 | -26.4% | 0.28% | -29.8% |
| Q1 2018 | $6,055,000 | -11.8% | 1,175,820 | -12.7% | 0.41% | -8.1% |
| Q4 2017 | $6,865,000 | -13.1% | 1,346,150 | -4.4% | 0.44% | -13.5% |
| Q3 2017 | $7,899,000 | -15.9% | 1,408,050 | -10.1% | 0.51% | -15.4% |
| Q2 2017 | $9,393,000 | +2.0% | 1,565,550 | +1.3% | 0.60% | +7.5% |
| Q1 2017 | $9,211,000 | -13.2% | 1,545,550 | +0.8% | 0.56% | -4.1% |
| Q4 2016 | $10,614,000 | -36.8% | 1,533,750 | +20.8% | 0.59% | -39.1% |
| Q3 2016 | $16,782,000 | +18.1% | 1,269,435 | +1.3% | 0.96% | +20.4% |
| Q2 2016 | $14,216,000 | -5.5% | 1,253,600 | -2.8% | 0.80% | +1.4% |
| Q1 2016 | $15,042,000 | +2.1% | 1,290,010 | +3.0% | 0.79% | +33.7% |
| Q4 2015 | $14,728,000 | +7.0% | 1,252,350 | +4.0% | 0.59% | +17.1% |
| Q3 2015 | $13,766,000 | -35.9% | 1,203,720 | +1.2% | 0.50% | -16.0% |
| Q2 2015 | $21,478,000 | -6.2% | 1,189,270 | -0.0% | 0.60% | +4.7% |
| Q1 2015 | $22,901,000 | +9.9% | 1,189,670 | 0.0% | 0.57% | +40.1% |
| Q4 2014 | $20,831,000 | -5.2% | 1,189,670 | -1.1% | 0.41% | -4.0% |
| Q3 2014 | $21,976,000 | -20.8% | 1,202,820 | -0.2% | 0.43% | -11.6% |
| Q2 2014 | $27,748,000 | -5.9% | 1,204,883 | -1.0% | 0.48% | -6.8% |
| Q1 2014 | $29,485,000 | -4.3% | 1,216,878 | -0.7% | 0.52% | -3.4% |
| Q4 2013 | $30,819,000 | +13.3% | 1,225,878 | -2.0% | 0.54% | +7.9% |
| Q3 2013 | $27,208,000 | +2.9% | 1,250,364 | -20.3% | 0.50% | +1.6% |
| Q2 2013 | $26,449,000 | – | 1,569,699 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 672,100 | $14,625,000 | 5.62% |
| GOLDMAN CAPITAL MANAGEMENT INC | 312,000 | $6,789,000 | 4.48% |
| Lyon Street Capital, LLC | 407,586 | $8,870,047,000 | 4.37% |
| GREAT POINT PARTNERS LLC | 189,071 | $4,114,000 | 2.85% |
| Adirondack Research & Management Inc. | 161,507 | $3,514,000 | 2.02% |
| Park West Asset Management LLC | 483,355 | $10,518,000 | 1.56% |
| Benchmark Capital Advisors | 56,954 | $1,239,000 | 0.89% |
| WOODMONT INVESTMENT COUNSEL LLC | 76,607 | $1,667,000 | 0.61% |
| SHEPHERD KAPLAN KROCHUK, LLC | 156,000 | $3,394,000 | 0.55% |
| HEARTLAND ADVISORS INC | 1,250,364 | $27,208,000 | 0.50% |